Contraindicated (1)pentobarbital will reduce the extent or effect of dienogest/estradiol valerate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Females shouldn't pick estradiol valerate/dienogest as their contraceptive when applying strong CYP3A4 inducers as a result of possible reduce in contraceptive efficacy.
pentobarbital will minimize the level or impact of ramelteon by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unfamiliar.
pentobarbital will lower the extent or impact of buprenorphine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lessen the extent or result of dienogest/estradiol valerate by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Ladies must not pick out estradiol valerate/dienogest as their contraceptive though working with sturdy CYP3A4 inducers resulting from likely reduce in contraceptive efficacy.
pentobarbital will lessen the level or result of quetiapine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Drugs that have stage therapy linked to Just about every prescription. This restriction usually demands that selected conditions be fulfilled just before acceptance for that prescription.
pentobarbital will minimize the level or effect of lopinavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will reduce the extent or impact of midazolam by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of.
pentobarbital will lower the extent or outcome of atorvastatin by impacting hepatic/intestinal here enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will decrease the level or influence of voriconazole by influencing hepatic enzyme CYP2C9/ten metabolism. Minor/Importance Unfamiliar.
pentobarbital will increase toxicity of buprenorphine, long-acting injection by pharmacodynamic synergism. Modify Therapy/Watch Closely. Coadministration of buprenorphine and benzodiazepines or other CNS depressants will increase risk of adverse reactions like overdose, respiratory despair, and death. Cessation of benzodiazepines or other CNS depressants is chosen in most cases.
pentobarbital will minimize the extent or outcome of dutasteride by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unfamiliar.
pentobarbital will lessen the extent or outcome of conjugated estrogens by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital will lower the extent or outcome of roflumilast by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration not advised; solid cytochrome P450 enzyme inducers minimize systemic publicity to roflumilast and may reduce the therapeutic efficiency